Single-cell RNA sequencing technologies are widely used in recent years as a powerful tool allowing the observation of gene expression at the resolution of single cells. Two of the major challenges in scRNA-seq data analysis are dropout events and batch effects. The inflation of zero(dropout rate) varies substantially across single cells. Evidence has shown that technical noise, including batch effects, explains a notable proportion of this cell-to-cell variation. To capture biological variation, it is necessary to quantify and remove technical variation. Here, we introduce SCRIBE (Single-Cell Recovery Imputation with Batch Effects), a principled framework that imputes dropout events and corrects batch effects simultaneously. We demonstrate, through real examples, that SCRIBE outperforms existing scRNA-seq data analysis tools in recovering cell-specific gene expression patterns, removing batch effects and retaining biological variation across cells.
Introduction
Though undergoing rapid development in recent years, single-cell RNA-sequencing (scRNA-seq) data analysis is challenging due to severe systematic errors including batch effects and dropout events [1] . Batch effects may result from laboratory conditions, reagent lots and personnel differences, etc [2] . Combining data from multiple batches can offset the restriction of sample size and increase statistical power. However, the existence of batch effects makes data integration difficult since they are often associated with an outcome of interest [3] . Since the earliest observation of batch effects in microarray experiments [4] , an explosion of batch effects correction methods for both bulk RNA-seq data [5] [6] [7] [8] [9] [10] [11] [12] [13] and scRNA-seq data [14] [15] [16] [17] [18] [19] have been developed over the past two decades. Moreover, the inflation of zero caused by dropout events [20] renders more noise to scRNA-seq data than bulk RNA-seq data. Evidence has shown that batch effects account for a substantial percentage of dropout variability at the cell level [1] . Many imputation methods have been proposed in recent years to recover dropouts [18, [21] [22] [23] [24] in scRNA-seq data. However, among these methods, only BUSseq [18] takes both batch effects and dropout events into consideration.
In this paper, we propose SCRIBE(Single-Cell Recovery Imputation with Batch Effects), a unified framework that jointly corrects batch effects and imputes dropout events across multiple biological groups. We apply SCRIBE to a single mouse neurons dataset to show that SCRIBE can accurately recover and correct batch effects for scRNA-seq data.
Method

SCRIBE model
We outline the framework of SCRIBE in this section. Let Y cg denote the observed read count of gene g cell c and Z cg be the dropout indicator. To account for dropout events and batch effects, we model Y cg by a hierarchical zero-inflated Poisson mixed model [25, 26] :
where log (λ cg ) = log µ G(c)g +log (r c )+log (l g )+b ig . µ G(c)g is the "true" normalized expression level for gene g of biological group G(c); r c is the library size of cell c; l g is the total read count of gene g and b ig is the random effect of batch i on gene g. We assume b ig ∼ N ν i , σ 2 i with a constraint i ν i = 0 to ensure the identifiability of the parameters. Z cg follows Bernoulli distribution with P (Z cg = 1) = Φ [γ i + α i log (r c ) + β i log (l g )]. γ i , α i and β i are batch specific dropout parameters of batch i to which cell c belongs. Φ (·) is the CDF of standard normal distribution.
SCRIBE estimation procedure
The estimation of parameters in SCRIBE model follows maximum likelihood estimation(MLE). We apply Monte-Carlo EM(MCEM) algorithm [27, 28] here. Define π cg = γ i + α i log (r c ) + β i log (l g ). In order to apply data augmentation algorithm [29] , we introduce a latent variable η cg ∼ N (π cg , 1) that satisfies Z cg = 1 {ηcg>0} . In MCEM, the random effect b ig and the data augmentation variables η cg are treated as missing data. In E step, with the help of Metropolis-Hastings algorithm [30, 31] , we sample b ig and η cg for K times from the posterior distribution conditioning on the preceding M step estimation of other parameters. We denote the posterior samples as b igk , η cgk and Z cgk = 1 {η cgk >0} , where k = {1, 2, . . . , K}. Then, in M step, the estimation of other parameters can be separated into three independent parts: (i) Estimation of µ G(c)g . Directly using MLE estimator, we havê µ Gg = K c∈G Y cg l g c∈G r c ( k exp (b igk Z cgk )) ; (ii) Estimation of γ i , α i and β i . We fit a batch specific linear model that regresses η cgk on log (r c ) and log (l g ) to get the estimationγ i , α i andβ i ; (iii) Estimation of ν i and σ 2 i . Restricted maximum likelihood(REML) is applied on b igk to estimateν i andσ i with the constraint i ν i = 0.
Dropout recovery imputation and batch effects correction
SCRIBE conducts data normalization, dropout imputation and batch effects correction simultaneously. Given the fitted model, defineΛ cg =μ G(c)g l g and letp cg be the estimation of posterior probability, i.e. p cg = P Z cg = 1 Y cg . To be specific,p cg = 1, if Y cg > 0. Otherwise, by Bayes' theorem:
whereπ cg andλ cg are the estimation of π cg and λ cg from the last iteration of MCEM, respectively. We develop a location and scale (L/S) adjustment [8] that retains the first and second moments of Poisson distribution. For Y cg > 0, the corrected dataỸ cg is given bỹ
For Y cg = 0,Ỹ cg is the sum of corrected expression level and dropout imputation weighted by their posterior probability:
Results
We use Usoskin's single mouse neurons dataset [32] to examine the performance of SCRIBE on imputing the zeros, correcting batch effects and whether the imputation and batch effects correction would outperform existing analysis tools. The cell labels are assigned by the authors. We choose 4 cell types(peptidergic nociceptors, non-peptidergic nociceptors, neurofilament containing and tyrosine hydroxylase containing) with enough sample sizes from two batches. Genes with no expression are discarded. The filtered dataset contains 19,212 genes and 420 cells(265 cells in batch1 and 155 cells in batch2).
Comparison with existing dropout imputation methods
In this section, we benchmark SCRIBE with existing imputation methods including BUSseq [18] , Drimpute [23] , scImpute [21] , SAVER [24] and MAGIC [22] . To generate realistic benchmarking datasets, we perform down-sampling experiments [24] on Usoskin dataset. We first select genes that have non-zero expression in at least 45% of the cells and cells with a library size of greater than 20,000 as the reference dataset, which we treat as the true expression. We end up with 3,156 genes and 244 cells(90 cells in batch1 and 154 cells in batch2) with detection rate 80.45%. Then, we randomly drop data in the reference dataset and generate an observed dataset. The probability of dropout is 0.2 for batch1 and 0.3 for batch2. The overall detection rate is 21.15% after artificial dropout events which is close to 20.33%, the overall detection rate of Usoskin dataset. All parameters are set to default for all the benchmarking imputation methods. To evaluate the performance of each method, we calculate the gene-wise Pearson correlation across cells and the cell-wise Pearson correlation across genes between the library-size normalized reference dataset and observed dataset, as well as between the normalized reference dataset and normalized observed dataset (Fig. 1a, b) . The results show that SCRIBE outperforms other methods on both the gene-wise and cell-wise correlations although SAVER performs comparably to SCRIBE in terms of cell-wise correlations. Then, we calculate correlation matrix distance (CMD) [33] between gene-to-gene and cell-to-cell correlation matrices recovered by benchmarking methods as well as observed data and the reference gene-to-gene and cell-to-cell correlation matrix. CMD is a measure of the distance between two correlation matrices ranging from 0 (equal) to 1 (maximum difference). For gene-to-gene CMD (Fig. 1c) , SCRIBE performs comparably to SAVER while it outperforms all other methods. For cell-to-cell CMD (Fig. 1d) , SCRIBE significantly improves the performance.
Comparison with existing batch effects correction methods
Next, we benchmark SCRIBE with existing scRNA-seq batch effects correction methods including BUSseq [18] , MNN [15] , Seurat [14] and ZINB-WaVE [16] . The number of cell types is input to BUSseq with all other parameters set to default. The With the ground truth reported by the original publication, we use the Adjusted Rand Index (ARI) which measures the consistency between two clustering results as the perfomance metric. Higher ARI suggests better performance on batch effects correction. We implement k-means for cell types clustering on each method except for BUSseq, which has its own inferred cell types. Our results of ARI are 0.930 for SCRIBE, 0.829 for BUSseq, 0.701 for MNN, 0.670 for Seurat and 0.904 for ZINB-WaVE. Uniform Manifold Approximation and Projection(UMAP) [34] plots show that SCRIBE outperforms all other methods on that SCRIBE can cluster the cells by cell types (Fig. 2) . We also calculate the silhouette width [35] to compare the clustering performance of the different methods to remove batch effects and combine data. A high value of silhouette width indicates that the cell is well matched to its own cluster and poorly matched to neighboring clusters.
Here, silhouette widths are calculated based on UMAP for either batch information or known sample group. Our results show that batch information after corrected by SCRIBE merges together and SCRIBE gives more concentration on high silhouette scores on cell types than other methods (Fig. 3 ).
Conclusion
Although our understanding of scRNA-seq data is still far from complete, we have gained valuable knowledge from the technique. To make full use of this tool and capture biological insights behind the data, we propose a new statistical framework based on zero-inflated Poisson mixed model for scRNA-seq data analysis. Real data results show that SCRIBE is a powerful method that jointly adjusts for batch effects and imputes dropout events. For dropout imputation, SCRIBE borrows information from same cell types across other batches to recover the true expression level; For batch effects correction, random effect model in SCRIBE provides more robust adjustment for the batch effects on each gene as well as retaining biological variation.
Future work. Directly following the current model, we can use the parameters and posterior distributions estimated by SCRIBE to develop a statistical inference procedure to test differential expression of markers across biological groups. New markers or cell types might be identified with this statistical testing procedure which will constitute the object of future studies.
